EyeWorld Weekly, October 3, 2025

➤ Phase 1/2 trial update for Leber congenital amaurosis gene therapy in pediatric patients ➤ Primary endpoint not met in Phase 2b trial investigating persistent corneal epithelial defect treatment ➤ Study: treatment for uveal melanoma could improve survival rate ➤ Company news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, October 3, 2025

EyeWorld Weekly, March 22, 2024

➤ Phase 3 results reported for novel glaucoma eye drop ➤ Update: preventative therapy for patients at risk for radiation retinopathy ➤ Topical drop for diabetic retinopathy does not meet endpoints in Phase 2 trial ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, March 22, 2024